Neuropathological investigation of 28 brains from patients with dyskinesia.
D000328:Adult; D000368:Aged; D000679:Amygdala / Q000473:pathology; D001479:Basal Ganglia / Q000473:pathology; D001921:Brain / Q000473:pathology*; D001933:Brain Stem / Q000473:pathology; D002540:Cerebral Cortex / Q000473:pathology; D003704:Dementia / Q000150:complications; D004565:Electroconvulsive Therapy / Q000009:adverse effects; D005260:Female; D005625:Frontal Lobe / Q000473:pathology; D006801:Humans; D008046:Lip / Q000503:physiopathology; D008297:Male; D008334:Mandible / Q000503:physiopathology; D008636:Mesencephalon / Q000473:pathology; D008875:Middle Aged; D009069:Movement Disorders / Q000209:etiology / Q000473:pathology*; D009420:Nervous System / Q000473:pathology; D019965:Neurocognitive Disorders / Q000150:complications; D009457:Neuroglia; D009912:Oral Manifestations; D009929:Organ Size; D011149:Pons / Q000473:pathology; D012559:Schizophrenia / Q000150:complications; D013378:Substantia Nigra / Q000473:pathology; D014059:Tongue / Q000503:physiopathology; D014149:Tranquilizing Agents / Q000009:adverse effects
D014149:Tranquilizing Agents